Mildred Olivier
Ophthalmology · Hoffman Estates, ILNPI 1063508190
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Aerie Pharmaceuticals, Inc. at 51.1% of the total. Reporting peaked in 2019 at $24,768 and has fallen 96.4% since, to $888 in 2025. Among ophthalmology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $524.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerie Pharmaceuticals, Inc.$29K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$8K
- Amgen$7K
- AbbVie$6K
- Bausch & Lomb Americas Inc.$4K
- Alcon$629
- plus $2K from 12 others
What the payments were for
- Consulting fees$32,14557%
- Speaking & faculty fees$14,13825%
- Travel & lodging$4,4638%
- Food & beverage$5,2719%
- Gifts$580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerie Pharmaceuticals, Inc. | 28 | $28,681 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $8,081 |
| Amgen(2 entities) | 5 | $6,580 |
| AbbVie(2 entities) | 21 | $6,030 |
| Bausch & Lomb Americas Inc. | 7 | $4,053 |
| Alcon | 9 | $629 |
| Sun Pharmaceutical Industries Inc. | 6 | $401 |
| Thea Pharma Inc. | 3 | $268 |
| NEW World Medical,inc. | 2 | $248 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $243 |
| Sight Sciences, Inc. | 2 | $167 |
| Carl Zeiss Meditec USA, Inc. | 1 | $135 |
| Tarsus Pharmaceuticals, Inc. | 2 | $134 |
| Ivantis, Inc | 1 | $133 |
| Oyster Point Pharma, Inc. | 1 | $108 |
| Glaukos Corporation | 2 | $102 |
| Carl Zeiss Meditec AG | 3 | $58 |
| Novartis | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VYZULTA$11,751
- TEPEZZA$6,463
- Rocklatan$4,925
- Rhopressa$4,298
- XEN GLAUCOMA TREATMENT SYSTEM$1,746
- LUMIGAN$1,619
- DURYSTA$1,350
- Ahmed Glaucoma Valve$248
- Kahook Dual Blade$248
- OMNI(R) SURGICAL SYSTEM (US)$150
- SION SURGICAL INSTRUMENT$150
- Hydrus Microstent$143
- ARTEVO 800$135
- Hydrus$133
- RESTASIS MULTIDOSE$130
- OZURDEX$130
- CEQUA$125
- AcrySof$116
- TYRVAYA$108
- Ryzumvi$108
How this compares
$56,076 in reported general payments places this provider in the 95th percentile of 773 ophthalmology providers in Illinois.
Other ophthalmology in Hoffman Estates
- Seenu HariprasadChicago$2.3M
- Lisa NijmSpringfield$1.7M
- Kathleen MornoNorth Riverside$1.2M
- Veeral ShethOak Forest$716K
- James KatzDes Plaines$642K
- Mitchell JacksonLake Villa$584K
- David LubeckHomewood$575K
- Parag MajmudarHighland Park$451K
- Daniel OwensLombard$343K
- Yannek LeidermanChicago$312K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.